• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复方血栓通通过靶向 YAP 保护视网膜血管内皮细胞免受高糖损伤。

Fufang Xueshuantong protects retinal vascular endothelial cells from high glucose by targeting YAP.

机构信息

College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China; Tsing biomedical research center, Lanzhou University Second Hospital, Lanzhou 730030, China.

College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.

出版信息

Biomed Pharmacother. 2019 Dec;120:109470. doi: 10.1016/j.biopha.2019.109470. Epub 2019 Oct 4.

DOI:10.1016/j.biopha.2019.109470
PMID:31590124
Abstract

Fufang Xueshuantong (FXST), a Chinese patent medicine, is composed of Panax notoginseng, Salviae miltiorrhizae, Astragali Radix and Radix Scrophulariae and has been found to prevent diabetic retinopathy. Yes-associated protein (YAP) participates in the pathophysiology of retinal disease and promotes endothelial cell proliferation and angiogenesis. Although it is known that YAP activity is altered by FXST, the role of YAP in mediating the effect of FXST remains unclear. In high glucose-treated retinal vascular endothelial cells (RVECs), FXST significantly reduced cell viability, the number of migrating cells and tube length in the present study. Moreover, FXST decreased the levels of YAP mRNA and protein and inhibited the expression of vascular endothelial growth factor (VEGF). Transfection of sh-YAP into the cells decreased the ability of FXST to modulate cell migration and tube formation. The effect of FXST on VEGF expression was also decreased. Similar results were obtained when the cells were stimulated with a YAP inhibitor in combination with FXST. Thus, FXST is shown to protect high glucose-injured RVECs via YAP-mediated effects.

摘要

复方血栓通(FXST)是一种中药,由三七、丹参、黄芪和玄参组成,已被发现可预防糖尿病视网膜病变。Yes 相关蛋白(YAP)参与视网膜疾病的病理生理学过程,并促进内皮细胞增殖和血管生成。虽然已知 FXST 会改变 YAP 的活性,但 YAP 在介导 FXST 作用中的作用尚不清楚。在高糖处理的视网膜血管内皮细胞(RVECs)中,FXST 在本研究中显著降低了细胞活力、迁移细胞数量和管腔长度。此外,FXST 降低了 YAP mRNA 和蛋白水平,并抑制了血管内皮生长因子(VEGF)的表达。将 sh-YAP 转染到细胞中降低了 FXST 调节细胞迁移和管状形成的能力。FXST 对 VEGF 表达的影响也降低了。当细胞同时受到 YAP 抑制剂和 FXST 的刺激时,也得到了类似的结果。因此,FXST 通过 YAP 介导的作用来保护高糖损伤的 RVECs。

相似文献

1
Fufang Xueshuantong protects retinal vascular endothelial cells from high glucose by targeting YAP.复方血栓通通过靶向 YAP 保护视网膜血管内皮细胞免受高糖损伤。
Biomed Pharmacother. 2019 Dec;120:109470. doi: 10.1016/j.biopha.2019.109470. Epub 2019 Oct 4.
2
Fufang Xueshuantong alleviates diabetic retinopathy by activating the PPAR signalling pathway and complement and coagulation cascades.复方血栓通通过激活 PPAR 信号通路和补体及凝血级联来缓解糖尿病视网膜病变。
J Ethnopharmacol. 2021 Jan 30;265:113324. doi: 10.1016/j.jep.2020.113324. Epub 2020 Sep 2.
3
A combination of the main constituents of Fufang Xueshuantong Capsules shows protective effects against streptozotocin-induced retinal lesions in rats.复方血栓通胶囊主要成分的组合对链脲佐菌素诱导的大鼠视网膜损伤具有保护作用。
J Ethnopharmacol. 2016 Apr 22;182:50-6. doi: 10.1016/j.jep.2015.11.021. Epub 2015 Dec 9.
4
YAP/TAZ Signaling Enhances Angiogenesis of Retinal Microvascular Endothelial Cells in a High-Glucose Environment.YAP/TAZ 信号在高糖环境中增强视网膜微血管内皮细胞的血管生成。
Curr Eye Res. 2024 May;49(5):524-532. doi: 10.1080/02713683.2024.2309217. Epub 2024 Feb 2.
5
Chinese medicinal formula Fufang Xueshuantong capsule could inhibit the activity of angiotensin converting enzyme.中药复方血栓通胶囊可抑制血管紧张素转换酶的活性。
Biotechnol Biotechnol Equip. 2014 Mar 4;28(2):322-326. doi: 10.1080/13102818.2014.911611. Epub 2014 Jul 18.
6
Network pharmacology analyses of the antithrombotic pharmacological mechanism of Fufang Xueshuantong Capsule with experimental support using disseminated intravascular coagulation rats.基于弥散性血管内凝血大鼠模型的实验支持,对复方血栓通胶囊抗血栓药理机制进行网络药理学分析。
J Ethnopharmacol. 2014 Jul 3;154(3):735-44. doi: 10.1016/j.jep.2014.04.048. Epub 2014 May 14.
7
Anti-angiogenic effect of adiponectin in human primary microvascular and macrovascular endothelial cells.脂联素对人原代微血管和大血管内皮细胞的抗血管生成作用。
Microvasc Res. 2019 Mar;122:136-145. doi: 10.1016/j.mvr.2018.08.002. Epub 2018 Aug 23.
8
YAP via interacting with STAT3 regulates VEGF-induced angiogenesis in human retinal microvascular endothelial cells.YAP 通过与 STAT3 相互作用调节人视网膜微血管内皮细胞中 VEGF 诱导的血管生成。
Exp Cell Res. 2018 Dec 15;373(1-2):155-163. doi: 10.1016/j.yexcr.2018.10.007. Epub 2018 Oct 17.
9
The Effects of the CXCR4 Antagonist, AMD3465, on Human Retinal Vascular Endothelial Cells (hRVECs) in a High Glucose Model of Diabetic Retinopathy.AMD3465 对糖尿病视网膜病变高糖模型中人视网膜血管内皮细胞(hRVECs)的影响。
Med Sci Monit. 2019 Sep 16;25:6946-6954. doi: 10.12659/MSM.917186.
10
Lonicerae Japonicae Flos attenuates diabetic retinopathy by inhibiting retinal angiogenesis.金银花通过抑制视网膜血管生成减轻糖尿病视网膜病变。
J Ethnopharmacol. 2016 Aug 2;189:117-25. doi: 10.1016/j.jep.2016.05.039. Epub 2016 May 16.

引用本文的文献

1
The Therapeutic Effect and Mechanism of Traditional Chinese Medicine in Type 2 Diabetes Mellitus and Its Complications.中药对2型糖尿病及其并发症的治疗作用及机制
Diabetes Metab Syndr Obes. 2025 May 15;18:1599-1627. doi: 10.2147/DMSO.S517874. eCollection 2025.
2
Clinical observations and mechanistic insights of traditional Chinese medicine in the management of diabetic retinopathy.糖尿病视网膜病变的中医药管理的临床观察和机制见解。
Pharm Biol. 2024 Dec;62(1):529-543. doi: 10.1080/13880209.2024.2369292. Epub 2024 Jun 26.
3
The Hippo signalling pathway and its impact on eye diseases.
Hippo 信号通路及其对眼部疾病的影响。
J Cell Mol Med. 2024 Apr;28(8):e18300. doi: 10.1111/jcmm.18300.
4
Hippo/YAP signaling pathway: a new therapeutic target for diabetes mellitus and vascular complications.河马/Yes相关蛋白信号通路:糖尿病及血管并发症的新治疗靶点。
Ther Adv Endocrinol Metab. 2023 Dec 25;14:20420188231220134. doi: 10.1177/20420188231220134. eCollection 2023.
5
The signaling pathways of traditional Chinese medicine in treating diabetic retinopathy.中药治疗糖尿病视网膜病变的信号通路
Front Pharmacol. 2023 Jun 19;14:1165649. doi: 10.3389/fphar.2023.1165649. eCollection 2023.
6
The comparative effects of oral Chinese patent medicines in non-proliferative diabetic retinopathy: A Bayesian network meta-analysis of randomized controlled trials.中文专利药治疗非增殖性糖尿病视网膜病变的比较效果:一项基于随机对照试验的贝叶斯网状 Meta 分析。
Front Endocrinol (Lausanne). 2023 Apr 3;14:1144290. doi: 10.3389/fendo.2023.1144290. eCollection 2023.
7
Traditional Chinese Medicine Injections for Diabetic Retinopathy: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.中药注射剂治疗糖尿病视网膜病变的系统评价和网状 Meta 分析。
J Integr Complement Med. 2022 Dec;28(12):927-939. doi: 10.1089/jicm.2021.0392. Epub 2022 Jul 20.
8
The Functional Vision Protection Effect of Danshensu via Dopamine D1 Receptors: In Vivo Study.丹参素通过多巴胺D1受体的功能性视觉保护作用:体内研究
Nutrients. 2021 Mar 17;13(3):978. doi: 10.3390/nu13030978.
9
Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy.基于网络药理学的方法比较预测复方血栓通胶囊和和血明目片治疗增殖性糖尿病视网膜病变的活性成分及分子靶点
Evid Based Complement Alternat Med. 2021 Mar 5;2021:6642600. doi: 10.1155/2021/6642600. eCollection 2021.